Press Release: Vidac Pharma : Sphene Equity Research Update Reaffirms "Buy" Rating on Vidac Pharma
Continued analyst endorsement underscores confidence in shareholder value and growth potentialVidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ)LONDON, UNITED KINGDOM, September 2, 2025 /EINPresswire.com/ -- Vidac Pharma ...
Read full article »
Vidac Pharma develops medicines to help people suffering from oncologic and dermatologic medical conditions.
Read more